VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $412,000 | -29.2% | 17,731 | -51.4% | 0.01% | +25.0% |
Q1 2018 | $582,000 | +50.0% | 36,512 | +95.7% | 0.00% | -20.0% |
Q4 2017 | $388,000 | +42.6% | 18,656 | -1.8% | 0.01% | +25.0% |
Q3 2017 | $272,000 | -17.3% | 19,006 | 0.0% | 0.00% | -20.0% |
Q2 2017 | $329,000 | +52.3% | 19,006 | -2.8% | 0.01% | +66.7% |
Q1 2017 | $216,000 | -15.3% | 19,556 | +678.5% | 0.00% | -25.0% |
Q4 2015 | $255,000 | -60.0% | 2,512 | -29.6% | 0.00% | -63.6% |
Q3 2015 | $637,000 | -8.2% | 3,567 | +14.1% | 0.01% | 0.0% |
Q2 2015 | $694,000 | +11.6% | 3,125 | -0.2% | 0.01% | +10.0% |
Q1 2015 | $622,000 | -7.7% | 3,131 | -33.6% | 0.01% | -9.1% |
Q4 2014 | $674,000 | +9.2% | 4,713 | +0.3% | 0.01% | +10.0% |
Q3 2014 | $617,000 | +5.3% | 4,700 | +1.1% | 0.01% | 0.0% |
Q2 2014 | $586,000 | -0.8% | 4,649 | +3.7% | 0.01% | 0.0% |
Q1 2014 | $591,000 | -12.2% | 4,482 | -21.8% | 0.01% | -16.7% |
Q4 2013 | $673,000 | +12.5% | 5,732 | 0.0% | 0.01% | +9.1% |
Q3 2013 | $598,000 | +21.5% | 5,732 | +0.3% | 0.01% | +22.2% |
Q2 2013 | $492,000 | +14.7% | 5,717 | 0.0% | 0.01% | +12.5% |
Q1 2013 | $429,000 | – | 5,717 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |